ANI Pharmaceuticals reported $1.34B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
AbbVie USD 136.17B 1B Mar/2025
ANI Pharmaceuticals USD 1.34B 50.57M Jun/2025
Aurora Cannabis CAD 837.84M 28.68M Jun/2025
Canopy Growth CAD 904.67M 259.55M Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Hikma Pharmaceutical USD 5.13B 286M Dec/2024
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Novartis USD 104.4B 2.15B Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Sun Pharmaceuticals INR 921.01B 39.85B Mar/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025